- Home
- TALO vs SLNO Comparison
TALO vs SLNO Comparison
Compare TALO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- SLNO
- Stock Information
- Founded
- TALO 2011
- SLNO 1999
- Country
- TALO United States
- SLNO United States
- Employees
- TALO N/A
- SLNO N/A
- Industry
- TALO Oil & Gas Production
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TALO Energy
- SLNO Health Care
- Exchange
- TALO Nasdaq
- SLNO Nasdaq
- Market Cap
- TALO 1.5B
- SLNO 3.8B
- IPO Year
- TALO N/A
- SLNO 2014
- Fundamental
- Price
- TALO $9.00
- SLNO $86.65
- Analyst Decision
- TALO Buy
- SLNO Strong Buy
- Analyst Count
- TALO 8
- SLNO 9
- Target Price
- TALO $14.25
- SLNO $103.33
- AVG Volume (30 Days)
- TALO 4.0M
- SLNO 1.1M
- Earning Date
- TALO 08-06-2025
- SLNO 08-06-2025
- Dividend Yield
- TALO N/A
- SLNO N/A
- EPS Growth
- TALO N/A
- SLNO N/A
- EPS
- TALO 0.14
- SLNO N/A
- Revenue
- TALO $2,055,748,000.00
- SLNO N/A
- Revenue This Year
- TALO N/A
- SLNO N/A
- Revenue Next Year
- TALO N/A
- SLNO N/A
- P/E Ratio
- TALO $59.96
- SLNO N/A
- Revenue Growth
- TALO 31.54
- SLNO N/A
- 52 Week Low
- TALO $6.23
- SLNO $39.73
- 52 Week High
- TALO $12.71
- SLNO $87.16
- Technical
- Relative Strength Index (RSI)
- TALO 51.52
- SLNO 67.62
- Support Level
- TALO $8.19
- SLNO $81.61
- Resistance Level
- TALO $8.79
- SLNO $86.79
- Average True Range (ATR)
- TALO 0.36
- SLNO 3.10
- MACD
- TALO -0.07
- SLNO 0.33
- Stochastic Oscillator
- TALO 29.13
- SLNO 95.37
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.